Bio-Pharma

Sunrise, Florida, USA, October 15, 2026 TranspireBio Holdings Inc. has presented an industry perspective on the U.S. Food and...

Cambridge, Massachusetts, USA, October 15, 2026 Marengo Therapeutics has received a second U.S. Food and Drug Administration (FDA) Fast...

Fort Lee, New Jersey, USA, October 14, 2026 Elevar Therapeutics has resubmitted a New Drug Application (NDA) to the...

Miami, Florida, USA, October 14, 2026 SAB Biotherapeutics, Inc. (SAB BIO), a clinical-stage biopharmaceutical company developing innovative immunotherapies for...

Osaka, Japan, and Cambridge, Massachusetts, USA, October 14, 2026 Takeda Pharmaceutical Company Limited has announced detailed results from the...

Washington, D.C., USA, October 14, 2026 Vanda Pharmaceuticals Inc. has announced results from its Phase III clinical trial of...

Burlingame, California, USA, October 14, 2026 Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative small-molecule medicines,...

Reykjavik, Iceland, and London, United Kingdom, October 14, 2026 Alvotech, a biotechnology company specializing in the development and manufacture...

San Diego, California, USA, October 14, 2026 Phanes Therapeutics, Inc., a clinical-stage biotechnology company focused on innovative immuno-oncology drug...

Paris, France, October 13, 2026 Enodia Therapeutics has announced a research collaboration and licensing agreement with Pfizer Inc. to...